Irinotecan Hydrochloride (BluePoint Laboratories)
Welcome to the PulseAid listing for the Irinotecan Hydrochloride drug offered from BluePoint Laboratories. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BluePoint Laboratories |
NON-PROPRIETARY NAME: | Irinotecan Hydrochloride |
SUBSTANCE NAME: | IRINOTECAN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-02-20 |
END MARKETING DATE: | 0000-00-00 |
Irinotecan Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Irinotecan Hydrochloride from BluePoint Laboratories |
LABELER NAME: | BluePoint Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2008-02-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68001-284_008d20d9-4743-4fc4-9570-d4d2f062c6a1 |
PRODUCT NDC: | 68001-284 |
APPLICATION NUMBER: | ANDA077219 |
Other IRINOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: